Cargando…
Degradation of HER2/neu by ANT2 shRNA suppresses migration and invasiveness of breast cancer cells
BACKGROUND: In breast cancer, the HER2/neu oncoprotein, which belongs to the epidermal growth factor receptor family, may trigger activation of the phosphoinositide-3 kinase (PI3K)/Akt pathway, which controls cell proliferation, survival, migration, and invasion. In this study, we examined the quest...
Autores principales: | Jang, Ji-Young, Jeon, Yoon-Kyung, Kim, Chul-Woo |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2919502/ https://www.ncbi.nlm.nih.gov/pubmed/20650008 http://dx.doi.org/10.1186/1471-2407-10-391 |
Ejemplares similares
-
ANT2 suppression by shRNA restores miR-636 expression, thereby downregulating Ras and inhibiting tumorigenesis of hepatocellular carcinoma
por: Jang, Ji-Young, et al.
Publicado: (2013) -
The combination of ANT2 shRNA and hNIS radioiodine gene therapy increases CTL cytotoxic activity through the phenotypic modulation of cancer cells: combination treatment with ANT2 shRNA and I-131
por: Choi, Yun, et al.
Publicado: (2013) -
Silencing of SOX12 by shRNA suppresses migration, invasion and proliferation of breast cancer cells
por: Ding, Hanzhi, et al.
Publicado: (2016) -
Adenovirus adenine nucleotide translocator-2 shRNA effectively induces apoptosis and enhances chemosensitivity by the down-regulation of ABCG2 in breast cancer stem-like cells
por: Jang, Ji-Young, et al.
Publicado: (2012) -
ANT2 shRNA downregulates miR-19a and miR-96 through the PI3K/Akt pathway
and suppresses tumor growth in hepatocellular carcinoma cells
por: Baik, Seung Hyun, et al.
Publicado: (2016)